Literature DB >> 7918765

Dissolution test method for rifampicin-isoniazid fixed dose formulations.

K C Jindal1, R S Chaudhary, A K Singla, S S Gangwal, S Khanna.   

Abstract

A dissolution procedure for a rifampicin-isoniazid combination formulation was evaluated using 0.1 N hydrochloric acid solution and 0.4% (w/v) sodium lauryl sulphate solution as dissolution media. Rifampicin and isoniazid along with degradation components were chromatographed using reversed-phase liquid chromatography on a 10 microns octadecylsilica column using methanol-0.01 M disodium hydrogen phosphate (70:30, v/v; pH 4.6 +/- 0.1) as mobile phase. The detection was carried out at 254 nm. The data obtained indicate that the dissolution medium consisting of 0.4% (w/v) sodium lauryl sulphate solution is suitable for such a combination. The degradation observed in dissolution medium consisting of 0.1 N hydrochloric acid was 10-23%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918765     DOI: 10.1016/0731-7085(94)80030-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.

Authors:  Sarita Rani; Avinash Gothwal; Pawan K Pandey; Devendra S Chauhan; Praveen K Pachouri; Umesh D Gupta; Umesh Gupta
Journal:  Pharm Res       Date:  2018-12-03       Impact factor: 4.200

2.  Drug-Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools.

Authors:  Mario-Livio Jeličić; Edvin Brusač; Stanislav Kurajica; Matija Cvetnić; Daniela Amidžić Klarić; Biljana Nigović; Ana Mornar
Journal:  Pharmaceutics       Date:  2021-03-17       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.